MNCM Expands Scope into HIE; Rebrands as MNSHINE
October 29, 2026
MN Community Measurement (MNCM) has announced plans to expand the scope of its work from quality measurement and reporting to broader health information exchange (HIE) services.
October 29, 2026
MN Community Measurement (MNCM) has announced plans to expand the scope of its work from quality measurement and reporting to broader health information exchange (HIE) services.
October 29, 2026
Next Tuesday, November 3, is Election Day. Make sure you have a plan to vote, if you haven’t already.
October 29, 2026
The Minnesota Health Equity Community of Practice (CoP) will host a virtual presentation on healthcare discrimination in Minnesota on December 8, from noon to 1 pm.
October 29, 2026
On October 21, CentraCare announced plans to acquire Stellis Health, yet another merger of healthcare entities in Minnesota.
October 29, 2026
The MMA is accepting applications from members interested in serving on the MMA Advocacy & Policy Committee (APC) for terms starting January 1, 2027.
October 29, 2026
Registration is now open for Physicians’ Day at the Capitol, when physicians and physicians-in-training from across the state gather at the Capitol to advocate on behalf of medicine.
October 21, 2026
The MMA will host a one-hour forum on Thursday, November 19 at 7pm, to discuss the impacts of The One Big Beautiful Bill Act.
October 21, 2026
The MMA will host a one-hour forum on Monday, November 9 at 7pm, to discuss medical lability in Minnesota. Read more here.
October 21, 2026
The Minnesota Department of Commerce is seeking physician input on proposed health insurance benefit mandates.
October 21, 2026
The MMA and the Minnesota Society of Addiction Medicine (MNSAM) are pleased to share a new clinical resource developed to support Minnesota clinicians caring for patients using concentrated 7-hydroxymitragynine (7-OH) and related kratom-derived products. The package provides practical guidance for assessment and buprenorphine initiation across inpatient, outpatient, and at-home settings. It is designed to help clinicians navigate an emerging area of practice where product potency and labeling may be unreliable, and the published treatment evidence remains limited.